These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands. Vrieling A, Voskuil DW, Bueno de Mesquita HB, Kaaks R, van Noord PA, Keinan-Boker L, van Gils CH, Peeters PH. Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992 [Abstract] [Full Text] [Related]
4. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk. Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ. Gynecol Endocrinol; 2005 Mar; 20(3):176-82. PubMed ID: 16019358 [Abstract] [Full Text] [Related]
5. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status. Barnes BB, Chang-Claude J, Flesch-Janys D, Kinscherf R, Schmidt M, Slanger T, Bonaterra G, Steindorf K. Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750 [Abstract] [Full Text] [Related]
6. Genetic and nongenetic factors associated with variation of plasma levels of insulin-like growth factor-I and insulin-like growth factor-binding protein-3 in healthy premenopausal women. Jernström H, Deal C, Wilkin F, Chu W, Tao Y, Majeed N, Hudson T, Narod SA, Pollak M. Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):377-84. PubMed ID: 11319179 [Abstract] [Full Text] [Related]
7. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults. Mattsson A, Svensson D, Schuett B, Osterziel KJ, Ranke MB. Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406 [Abstract] [Full Text] [Related]
8. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Krajcik RA, Borofsky ND, Massardo S, Orentreich N. Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045 [Abstract] [Full Text] [Related]
9. Plasma concentrations of insulin-like growth factors among healthy adult men and postmenopausal women: associations with body composition, lifestyle, and reproductive factors. Chang S, Wu X, Yu H, Spitz MR. Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):758-66. PubMed ID: 12163330 [Abstract] [Full Text] [Related]
10. Urinary 6-sulfatoxymelatonin levels and their correlations with lifestyle factors and steroid hormone levels. Schernhammer ES, Kroenke CH, Dowsett M, Folkerd E, Hankinson SE. J Pineal Res; 2006 Mar; 40(2):116-24. PubMed ID: 16441548 [Abstract] [Full Text] [Related]
11. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children. Gunnell D, Miller LL, Rogers I, Holly JM, ALSPAC Study Team. Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982 [Abstract] [Full Text] [Related]
12. Body shape throughout life and correlations with IGFs and GH. Schernhammer ES, Tworoger SS, Eliassen AH, Missmer SA, Holly JM, Pollak MN, Hankinson SE. Endocr Relat Cancer; 2007 Sep; 14(3):721-32. PubMed ID: 17914102 [Abstract] [Full Text] [Related]
13. Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis. Kawachi S, Takeda N, Sasaki A, Kokubo Y, Takami K, Sarui H, Hayashi M, Yamakita N, Yasuda K. Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):617-21. PubMed ID: 15625284 [Abstract] [Full Text] [Related]
14. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort. Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M. Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720 [Abstract] [Full Text] [Related]
15. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH. Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):748-52. PubMed ID: 15159305 [Abstract] [Full Text] [Related]
16. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer. Baglietto L, English DR, Hopper JL, Morris HA, Tilley WD, Giles GG. Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768 [Abstract] [Full Text] [Related]
17. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA. Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):607-12. PubMed ID: 15066926 [Abstract] [Full Text] [Related]
18. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Kahán Z, Gardi J, Nyári T, Földesi I, Hajnal-Papp R, Ormándi K, Lázár G, Thurzó L, Schally AV. Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200 [Abstract] [Full Text] [Related]
19. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Undén AL, Elofsson S, Brismar K. Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068 [Abstract] [Full Text] [Related]
20. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Hunt KJ, Lukanova A, Rinaldi S, Lundin E, Norat T, Palmqvist R, Stattin P, Riboli E, Hallmans G, Kaaks R. Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135 [Abstract] [Full Text] [Related] Page: [Next] [New Search]